Macquarie Group’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-9,215
Closed -$25 1975
2024
Q1
$25 Buy
+9,215
New +$22.4K ﹤0.01% 1679
2021
Q4
Sell
-976
Closed -$12K 2618
2021
Q3
$12K Hold
976
﹤0.01% 2523
2021
Q2
$21K Hold
976
﹤0.01% 2351
2021
Q1
$27K Sell
976
-390
-29% -$11.5K ﹤0.01% 2217
2020
Q4
$36K Hold
1,366
﹤0.01% 2110
2020
Q3
$51K Hold
1,366
﹤0.01% 1950
2020
Q2
$70K Buy
+1,366
New +$57.2K ﹤0.01% 1850
2018
Q3
Sell
-16,395
Closed -$642K 2185
2018
Q2
$642K Sell
16,395
-35,364
-68% -$1.79M ﹤0.01% 1291
2018
Q1
$3.74M Buy
51,759
+31,048
+150% +$2.28M 0.01% 835
2017
Q4
$1.36M Sell
20,711
-2,618
-11% -$141K ﹤0.01% 1146
2017
Q3
$1.17M Sell
23,329
-2,220
-9% -$107K ﹤0.01% 1159
2017
Q2
$1.18M Buy
+25,549
New +$940K ﹤0.01% 1117

Other funds holding ESPR